On Monday, medical device maker Medtronic entered a definitive agreement to acquire HeartWare International Inc. an innovator of less-invasive, miniaturized circulatory support technologies for the treatment of advanced heart failure for $1.1 billion. The acquisition is expected to close during Medtronic's second fiscal quarter ending Oct. 28, 2016. Here are 9 things to know about the acquisition: 1. As part of the agreement, Medtronic will pay $58 for each Heartware share outstanding, which
Read More
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Footer
